Search

Your search keyword '"Font, P. (Patricia)"' showing total 5 results
Start Over Author "Font, P. (Patricia)"
5 results on '"Font, P. (Patricia)"'

1. Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

Author

Gómez-Centurión, Ignacio, Oarbeascoa, Gillen, García, María Carmen, López Fresneña, María Carmen, Martínez Carreño, María Josefa, Escudero Vilaplana, Vicente, González-Haba, Eva, Bailén, Rebeca, Dorado, Nieves, Juárez, Luis Miguel, Rodríguez Macías, Gabriela, Font López, Patricia, Encinas, Cristina, Bastos-Oreiro, Mariana, Anguita, Javier, Sanjurjo, María, Díez-Martin, José Luis, and Kwon, Mi

Published
2022
Full Text
View/download PDF

2. Standardization of flow cytometry in myelodysplastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

Author

Loosdrecht, A.A. (Arjan) van de, Alhan, C. (Canan), Béné, M.C., Della Porta, M.G. (Matteo), Dräger, A.M. (Angelika), Feuillard, J. (Jean), Font, P. (Patricia), Germing, U. (Ulrich), Haase, D. (Detlef), Homburg, C.H. (Christa), Ireland, R. (Robin), Jansen, J.H. (Joop), Kern, W. (Wolfgang), Malcovati, L. (Luca), Marvelde, J.G. (Jeroen) te, Mufti, G.J. (Ghulam), Ogata, K. (Kiyoyuki), Orfao, A. (Alberto), Ossenkoppele, G.J. (Gert), Porwit, A. (Anna), Preijers, F.W.M.B. (Frank), Richards, S.J. (Stephen), Schuurhuis, G.J. (Gerrit Jan), Subirá, D. (Dolores), Valent, P. (Peter), Velden, V.H.J. (Vincent) van der, Vyas, P. (Paresh), Westra, A.H. (August), Witte, T. de, Wells, D.A. (Denise), Loken, M.R. (Michael), Westers, T.M. (Theresia), Loosdrecht, A.A. (Arjan) van de, Alhan, C. (Canan), Béné, M.C., Della Porta, M.G. (Matteo), Dräger, A.M. (Angelika), Feuillard, J. (Jean), Font, P. (Patricia), Germing, U. (Ulrich), Haase, D. (Detlef), Homburg, C.H. (Christa), Ireland, R. (Robin), Jansen, J.H. (Joop), Kern, W. (Wolfgang), Malcovati, L. (Luca), Marvelde, J.G. (Jeroen) te, Mufti, G.J. (Ghulam), Ogata, K. (Kiyoyuki), Orfao, A. (Alberto), Ossenkoppele, G.J. (Gert), Porwit, A. (Anna), Preijers, F.W.M.B. (Frank), Richards, S.J. (Stephen), Schuurhuis, G.J. (Gerrit Jan), Subirá, D. (Dolores), Valent, P. (Peter), Velden, V.H.J. (Vincent) van der, Vyas, P. (Paresh), Westra, A.H. (August), Witte, T. de, Wells, D.A. (Denise), Loken, M.R. (Michael), and Westers, T.M. (Theresia)

Abstract

The myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more cell lineages and increased risk of evolution to acute myeloid leukemia (AML). Recent advances in immunophenotyping of hematopoietic progenitor and maturing cells in dysplastic bone marrow point to a useful role for multiparameter flow cytometry (FCM) in the diagnosis and prognostication of myelodysplastic syndromes. In March 2008, representatives from 18 European institutes participated in a European LeukemiaNet (ELN) workshop held in Amsterdam as a first step towards standardization of FCM in myelodysplastic syndromes. Con

Published
2009
Full Text
View/download PDF

3. Patients with Acute Myeloid Leukemia on Non-Intensive Therapy: Applicability of the European Leukemia Net Risk Classification

Author

Silva, Pablo, Badiola, Jon, Martín-Rojas, Reyes María, Gómez-Centurión, Ignacio, Rodríguez-Macias, Gabriela, Gómez-Llobell, Marina, Martínez-Laperche, Carolina, Carbonell, Diego, Ballesteros, Mónica, Pérez-Corral, Ana, Chicano, María, Font Lopez, Patricia, Pérez-Sánchez, Isabel, Buño, Ismael, Anguita, Javier, Kwon, Mi, and Díez-Martín, José Luis

Abstract

BACKGROUND

Published
2021
Full Text
View/download PDF

4. Day 14 Measurable Residual Disease As a Predictor of Post-Induction Response in Patients with Acute Myeloid Leukemia

Author

Martín-Rojas, Reyes María, Badiola, Jon, Silva De Tena, Pablo, Pérez-Corral, Ana, Gómez-Centurión, Ignacio, Rodríguez-Macias, Gabriela, Ballesteros, Mónica, Martínez-Laperche, Carolina, Font Lopez, Patricia, Pérez-Sánchez, Isabel, Buño, Ismael, Anguita, Javier, Kwon, Mi, and Diez-Martin, Jose L.

Abstract

INTRODUCTION

Published
2021
Full Text
View/download PDF

5. Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ¿Is the Threshold of 20% Bone Marrow Blasts Reproducible?

Author

Font Lopez, Patricia, Loscertales, Javier, Lopez Rubio, Montserrat, Cedena, María Teresa, Soto, Carlos, Seri, Cristina, Ricard, Pilar, Ballesteros, Mónica, Benavente, Celina, Piris-Villaespesa, Miguel, Muñoz, Carolina, García Alonso, Luis, Bermejo, Alfredo, Perez Segura, Gloria, Gomez Rojas, Sandra, Castilla, Lucia, Jimenez Chillon, Carlos, Ortuzar, Ariana, Bellon, Jose Maria, Villarrubia, Jesus, Diez-Martin, Jose L., and Villegas, Ana

Abstract

Introduction. The boundaries between MDS and AML are still a matter of debate. In the 2001 WHO Classification, the myeloblast count distinguishing AML and MDS was lowered from 30% to 20% of the bone marrow (BM) cells or peripheral blood (PB) leukocytes. It was justified on the basis that treating patients with 20-29% BM blasts with intensive chemotherapy showed a similar outcome to those with > 30% BM blasts.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results